NextTrip NTRP insider converts Series Q preferred into 13,580 common
Rhea-AI Filing Summary
NextTrip, Inc. (NTRP) director reported a stock conversion. On November 21, 2025, the reporting person converted 13,580 shares of Series Q Nonvoting Convertible Preferred Stock into 13,580 shares of common stock at a stated price of $0.0 per share. This followed stockholder approval received on November 19, 2025. After the transaction, the reporting person directly owned 13,580 common shares and no Series Q preferred shares, reflecting a change in the form of ownership rather than a new cash investment.
Positive
- None.
Negative
- None.
Insights
Routine preferred-to-common conversion changes share class, not cash position.
The filing shows a director of NextTrip, Inc. converting 13,580 shares of Series Q Nonvoting Convertible Preferred Stock into the same number of common shares on November 21, 2025. The stated conversion price is $0.0 per share, indicating a non-cash, structural change in the type of security held.
The conversion occurred after stockholder approval obtained on November 19, 2025, which was a condition for the preferred shares to convert into common stock. Following the transaction, the director held 13,580 common shares directly and no Series Q preferred shares, so the key effect is a shift into voting equity that participates directly in the common stock’s economic and governance profile.
This type of transaction is typical for preferred instruments designed to convert upon a specific approval event. The impact on the broader shareholder base depends on how these 13,580 new common shares compare to total shares outstanding, which is not detailed in this excerpt.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series Q Nonvoting Convertible Preferred Stock | 13,580 | $0.00 | -- |
| Conversion | Common Stock | 13,580 | $0.00 | -- |
Footnotes (1)
- Each share of Series Q Nonvoting Convertible Preferred Stock was converted into one share of Common Stock upon receipt of stockholder approval, which approval was obtained on November 19, 2025, and the underlying Common Stock shares were issued on November 21, 2025. The shares have no expiration date.